Rybelsus and Synjardy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rybelsus (semaglutide) and Synjardy (empagliflozin; metformin hydrochloride). Common drug interactions include nausea among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Rybelsus and Synjardy. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Rybelsus?

Rybelsus has active ingredients of semaglutide. eHealthMe is studying from 4,159 Rybelsus users. Check the latest studies of Rybelsus.

What is Synjardy?

Synjardy has active ingredients of empagliflozin; metformin hydrochloride. eHealthMe is studying from 2,928 Synjardy users. Check the latest studies of Synjardy.



On Aug, 11, 2026

14 people who take Rybelsus and Synjardy together, and have interactions are studied.

Rybelsus and Synjardy drug interactions.

What are the common drug interactions of Rybelsus and Synjardy, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  4. Hypophagia (reduced food intake)
  5. Poor venous access
  6. Abdominal distension
  7. Abdominal pain upper
  8. Decreased appetite
  9. Eructation (release of gas from the digestive tract)
  10. Fatigue (feeling of tiredness)

male:

  1. Vomiting
  2. Nausea (feeling of having an urge to vomit)
  3. Food aversion (we reject certain foods for a reason)
  4. Neuropathy peripheral (surface nerve damage)
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Diarrhoea
  7. Ketoacidosis (high concentrations of ketone bodies in blood)
  8. Hypophagia (reduced food intake)
  9. Poor venous access
  10. Constipation

What are the common drug interactions of Rybelsus and Synjardy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Decreased appetite
  2. Fatigue (feeling of tiredness)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Nausea (feeling of having an urge to vomit)
  5. Vaginal haemorrhage (vaginal bleeding)
  6. Vomiting

40-49:

n/a

50-59:

  1. Constipation
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)

60+:

  1. Vomiting
  2. Nausea (feeling of having an urge to vomit)
  3. Food aversion (we reject certain foods for a reason)
  4. Ketosis (a state of elevated levels of ketone bodies in the body)
  5. Loss of consciousness
  6. Hypophagia (reduced food intake)
  7. Ketoacidosis (high concentrations of ketone bodies in blood)
  8. Poor venous access
  9. Diarrhoea
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

  1. Diabetes: 7 people, 50.00%
  2. Type 2 Diabetes: 3 people, 21.43%
  3. Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 14.29%
  4. Depression: 1 person, 7.14%
  5. Diarrhea: 1 person, 7.14%
  6. Headache (pain in head): 1 person, 7.14%
  7. High Blood Pressure: 1 person, 7.14%
  8. Hypokalemia (low potassium): 1 person, 7.14%
  9. Hypotension (abnormally low blood pressure): 1 person, 7.14%
  10. Vitiligo (pigment is lost from areas of the skin): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Rybelsus and Synjardy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rybelsus and Synjardy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rybelsus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Synjardy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rybelsus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synjardy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide and empagliflozin; metformin hydrochloride (the active ingredients of Rybelsus and Synjardy, respectively), and Rybelsus and Synjardy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: